Viva Biotech Holdings (VBIZF)

Viva Biotech Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	443	234	288	430	1,160	2,256
Market Cap Growth	-18.73%	-18.73%	-33.03%	-62.94%	-48.59%	146.75%
Enterprise Value	492	306	541	745	1,346	2,058
Last Close Price	0.24	0.07	0.12	0.24	0.60	1.20
PE Ratio	19.34	10.21	-	-	25.63	-
PS Ratio	1.63	0.86	0.95	1.25	3.50	21.13
PB Ratio	0.85	0.45	0.55	0.82	1.88	3.92
P/TBV Ratio	2.53	1.33	1.84	3.05	6.01	10.23
P/FCF Ratio	17.65	9.32	10.43	21.69	-	-
P/OCF Ratio	8.65	4.57	5.32	7.68	94.67	341.11
EV/Sales Ratio	1.83	1.12	1.78	2.16	4.06	19.28
EV/EBITDA Ratio	8.18	5.16	9.81	11.78	23.11	81.76
EV/EBIT Ratio	15.79	9.71	19.92	19.32	36.09	119.41
EV/FCF Ratio	19.57	12.17	19.61	37.58	-	-
Debt / Equity Ratio	0.34	0.34	0.52	0.78	0.68	0.79
Debt / EBITDA Ratio	2.90	2.90	4.71	6.25	6.81	16.25
Debt / FCF Ratio	7.01	7.01	9.72	20.65	-	-
Asset Turnover	0.27	0.27	0.28	0.30	0.26	0.14
Inventory Turnover	4.88	4.88	4.84	5.61	7.33	4.53
Quick Ratio	1.26	1.26	1.03	0.44	1.44	3.75
Current Ratio	1.67	1.67	1.32	0.73	2.14	4.56
Return on Equity (ROE)	5.92%	5.92%	-2.74%	-13.41%	7.84%	-13.69%
Return on Assets (ROA)	1.98%	1.98%	1.57%	2.08%	1.83%	1.40%
Return on Capital (ROIC)	2.69%	2.69%	2.00%	2.56%	2.23%	1.65%
Return on Capital Employed (ROCE)	3.90%	3.90%	3.30%	5.10%	3.30%	1.50%
Earnings Yield	5.17%	9.80%	-5.69%	-17.82%	3.90%	-2.63%
FCF Yield	5.67%	10.73%	9.59%	4.61%	-6.61%	-3.73%
Dividend Yield	-	-	-	-	-	0.30%
Payout Ratio	-	-	-	-	5.66%	-
Buyback Yield / Dilution	-41.39%	-41.39%	-5.91%	2.81%	-25.41%	-5.83%
Total Shareholder Return	-	-41.39%	-5.91%	2.81%	-25.41%	-5.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.